ClearBridge Emerging Markets Fund - Class FI (MEFIX) is an open-end mutual fund that seeks long-term capital appreciation through investments in equity and related securities of issuers located in or deriving substantial business from emerging market and developing countries, including Asia, the Indian subcontinent, Latin/Central America, the Middle East, Eastern/Central Europe and Africa. The fund employs a fundamentals-based, high-conviction, risk-aware investment approach with ESG analysis embedded in the process; it maintains a concentrated portfolio of 40-60 stocks, primarily in information technology, financials, consumer discretionary, communication services and industrials sectors, benchmarked against the MSCI Emerging Markets Index-NR. As of late 2025, the fund holds total net assets of approximately $307 million across 54 holdings, with a portfolio turnover of 19% and annual dividend distributions.
The fund targets institutional and financial intermediary investors seeking exposure to diversified emerging markets through a growth-oriented, all-cap core strategy that emphasizes quality companies with robust balance sheets and growth potential; geographic focus spans major emerging regions without fixed country or sector allocations beyond stock selection constraints. ClearBridge Investments, the fund's adviser and a subsidiary of Franklin Templeton, traces its origins to 1962 and maintains global headquarters in New York with additional offices in Baltimore, Calgary, Edinburgh, Fort Lauderdale, Leeds, London, Melbourne and Sydney.
In a significant recent development, effective September 30, 2025, the fund underwent a name change from Martin Currie Emerging Markets Fund to ClearBridge Emerging Markets Fund, reflecting integration under ClearBridge Investments following Franklin Templeton's acquisition of Martin Currie; this rebranding aligns with ClearBridge's expanded role as Franklin Templeton's largest equity specialist managing over $200 billion in assets. Portfolio adjustments in late 2025 included adding positions in Brazilian pharmacy operator Raia Drogasil and fintech company Nu Holdings while exiting one holding, underscoring ongoing active management amid market rotations in regions like China, Taiwan, Korea and India.